MCAM and ovarian carcinoma: For this purpose, these METCAM/MUC18 derivatives may be covalently linked to a platinum drug (such as carboplatin) to form a new platinum drug [48] and delivered specifically to ovarian carcinoma by properly designed nanoparticles [47,48].